Methylated DNA as a possible screening marker for neoplastic disease in several body fluids

被引:39
作者
Müller, HM [1 ]
Widschwendter, M [1 ]
机构
[1] Univ Innsbruck Hosp, Dept Obstet & Gynecol, A-6020 Innsbruck, Austria
关键词
body fluid; DNA methylation; early detection; free DNA; neoplasia; plasma; screening marker; serum;
D O I
10.1586/14737159.3.4.443
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Early detection appears to be one of the most important approaches to reducing mortality caused by neoplasia. Changes in DNA methylation have been recognized as one of the most common molecular alterations in human tumors. Due to the ubiquity of DNA methylation changes and the possibility to detect methylated DNA in several body fluids, this specifically altered DNA may serve as a potential new screening marker for neoplastic disease.
引用
收藏
页码:443 / 458
页数:16
相关论文
共 147 条
[11]   Alterations in DNA methylation are early, but not initial, events in ovarian tumorigenesis [J].
Cheng, P ;
Schmutte, C ;
Cofer, KF ;
Felix, JC ;
Yu, MC ;
Dubeau, L .
BRITISH JOURNAL OF CANCER, 1997, 75 (03) :396-402
[12]  
Corn PG, 2001, CLIN CANCER RES, V7, P2765
[13]   Loss of IGF2 imprinting:: A potential marker of colorectal cancer risk [J].
Cui, HM ;
Cruz-Correa, M ;
Giardiello, FM ;
Hutcheon, DF ;
Kafonek, DR ;
Brandenburg, S ;
Wu, YQ ;
He, XB ;
Powe, NR ;
Feinberg, AP .
SCIENCE, 2003, 299 (5613) :1753-1755
[14]  
Dong SM, 2001, CLIN CANCER RES, V7, P1982
[15]   Transcriptional inactivation of TP73 expression in oligodendroglial tumors [J].
Dong, SM ;
Pang, JCS ;
Hu, J ;
Zhou, LF ;
Ng, HK .
INTERNATIONAL JOURNAL OF CANCER, 2002, 98 (03) :370-375
[16]  
Du Y, 2001, CANCER RES, V61, P8094
[17]  
Eads CA, 2001, CANCER RES, V61, P3410
[18]  
Eads CA, 2000, CANCER RES, V60, P5021
[19]   MethyLight: a high-throughput assay to measure DNA methylation [J].
Eads, Cindy A. ;
Danenberg, Kathleen D. ;
Kawakami, Kazuyuki ;
Saltz, Leonard B. ;
Blake, Corey ;
Shibata, Darryl ;
Danenberg, Peter V. ;
Laird, Peter W. .
NUCLEIC ACIDS RESEARCH, 2000, 28 (08) :32
[20]   Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors [J].
Esteller, M ;
Silva, JM ;
Dominguez, G ;
Bonilla, F ;
Matias-Guiu, X ;
Lerma, E ;
Bussaglia, E ;
Prat, J ;
Harkes, IC ;
Repasky, EA ;
Gabrielson, E ;
Schutte, M ;
Baylin, SB ;
Herman, JG .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (07) :564-569